Viva BioInnovator
@vivabioinnovator.com
We are committed to being a collaborative platform for Innovative Biotech companies from around the world. As the investment division of Viva Biotech Holdings (1873.HK), our commitment is to operate a platform for anyone aiming to develop an idea with transformative potential. We are dedicated to the identification and success of early-stage biotech start-ups for Viva’s investment and incubation tracks. With a team of experts from across the healthcare industry and over $140 M invested, our goal is to help spark a wave of innovation that provides hope and new treatments for patients in need.
Viva BioInnovator's Company Logos


Viva BioInnovator's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
#030303
Black
3, 3, 3
0, 0, 1
0, 0, 0, 99
About Viva BioInnovator
Viva BioInnovator is a global brand dedicated to investing in biotech innovation and finding novel solutions to unmet medical needs. They prioritize early-stage therapeutics and aim to transform the lives of patients and their families through groundbreaking science and outstanding teams. With a focus on biopharmaceuticals, devices, diagnostics, and life science tools, Viva BioInnovator invests in cash and in-kind services for the development of new therapies.
In addition to financial support, they offer value-added services through their incubation track, including operational and logistical support for start-ups in their early-stage development. Viva BioInnovator assesses investment opportunities based on four key criteria: groundbreaking innovation, a strong team, commercial viability, and strategic fit. Their portfolio companies have access to capital, expert guidance, and a wide network of industry connections.
Viva BioInnovator aims to be a partner for founders with innovative ideas, providing support through two tracks: investment and incubation. They are committed to catalyzing innovation and growth, helping companies from '0 to 1' transformation, and addressing the needs of patients worldwide
